Last update 11 Dec 2024
Recombinant human insulin(Hefei Tianmai Biotechnology Development Co., Ltd.)
Last update 11 Dec 2024
Overview
Basic Info
Drug Type Biosimilar, Hormone |
Synonyms Insulin human Biosimilar (Hefei Tianmai Biotechnology Development Co., Ltd.), 人胰岛素生物类似药（合肥天麦生物科技发展有限公司）, 天麦霖 |
Target |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (28 Apr 2018), |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Recombinant human insulin(Hefei Tianmai Biotechnology Development Co., Ltd.)重组人胰岛素注射液在健康中国男性受试者中的生物利用度和生物等效性
[Translation] Bioavailability and bioequivalence of recombinant human insulin injection in healthy Chinese male subjects
100 Clinical Results associated with Recombinant human insulin(Hefei Tianmai Biotechnology Development Co., Ltd.)
Login to view more data
100 Translational Medicine associated with Recombinant human insulin(Hefei Tianmai Biotechnology Development Co., Ltd.)
Login to view more data
100 Patents (Medical) associated with Recombinant human insulin(Hefei Tianmai Biotechnology Development Co., Ltd.)
Login to view more data
100 Deals associated with Recombinant human insulin(Hefei Tianmai Biotechnology Development Co., Ltd.)
Login to view more data
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Diabetes Mellitus | CN | 28 Apr 2018 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free